Catch up on articles from the world of science you may have missed from October 2020. This month we take a look at dark matter, and whether any human experience can really be classed as universal.
Certain regulations on vehicles and carbon dioxide emission targets are currently regulated by the EU. The UK Government has put in place statutory instruments intended to retain these regulations when the transition period ends for leaving the EU. This article looks at three draft SIs which make amendments to current legislation to ensure the regulations can function effectively after the transition period, and that the UK meets its obligations under the Ireland/Northern Ireland Protocol.
The regulation of organic products, and of genetically modified organisms, is based on EU law. The European Union (Withdrawal) Act 2018 brings this EU law into UK statute, so that it will continue to have effect after the end of the transition period. Amendments since have ensured that the retained law refers to the UK system, not the EU. However, under the Northern Ireland Protocol, Northern Ireland will remain subject to the EU’s laws. This article looks at two statutory instruments that further amend the 2019 regulations so that they refer only to Great Britain, enabling Northern Ireland to continue to meet EU law.
The High Speed Rail (West Midlands–Crewe) Bill would provide approval for phase 2a of the High Speed 2 (HS2) railway line. Phase 2a would run between the West Midlands, where it would link with phase 1 of HS2, and Crewe. The bill is scheduled to begin its committee stage in the House of Lords on 9 November 2020.
The draft Timber and Timber Products and FLEGT (Amendment) (EU Exit) Regulations 2020 would amend the retained EU law prohibiting the sale of illegally harvested timber. The purpose of the amendments is to implement the Protocol on Ireland/Northern Ireland, such that the relevant EU regulations continue to apply in Northern Ireland.
Almost 200 Covid-19 vaccine candidates are currently being developed. However, only a tiny percentage of these will ever be mass-produced and distributed. Concerns around ‘vaccine nationalism’ have grown, as high-income countries pre-order hundreds of millions of vaccine doses. This article looks at this problem and examines what solutions are being put in place to ensure low and middle income countries receive adequate supplies of any successful Covid-19 vaccine.
Catch up on articles you may have missed from the world of science. This month we look at how infants acquire language, and the rise of algorithms in the workplace.
In recent months there has been a renewed focus on the future of hydrogen as a low carbon energy carrier for the UK. This had led to calls from a variety of individuals and organisations for the Government and the newly formed Hydrogen Advisory Council to publish a hydrogen strategy. This issue is due to be the subject of an oral question in the House of Lords on 17 September 2020.
A government advisory body has updated its recommendations on how much of the UK’s electricity should be generated from renewables. What sparked the change?
Scientific research in universities is funded through a mix of public money, EU funding and other sources. This article considers the House of Lords Science and Technology Committee report on the pressures on science research funding in universities, including proposals in the Augar Review to lower the existing cap on tuition fees and the potential impact of Brexit. The committee’s report is due to debated in the House of Lords on 9 September 2020.
From October 2020, the Government plans to restrict the supply of certain single-use plastics. This article discusses the regulations which would provide for this change.
Xylella fastidiosa is a bacteria that can cause severe disease and death in certain plants. This article explains what the disease is and discusses recent restrictions on plant imports that the UK Government has imposed to reduce the risk of it being introduced to the UK. Xylella is due to be the subject of an oral question in the House of Lords on 8 July 2020.
This article looks at the current candidates for a Covid-19 vaccine, focusing on the University of Oxford/AstraZeneca project, and the Moderna candidate from the US National Institute of Allergy and Infectious Diseases. The article highlights the new mRNA technology being developed in some projects. It also looks at what the Government is doing to support vaccine development.